David Tanous

1.2k total citations
36 papers, 775 citations indexed

About

David Tanous is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Tanous has authored 36 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 21 papers in Pulmonary and Respiratory Medicine and 20 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Tanous's work include Congenital Heart Disease Studies (23 papers), Coronary Artery Anomalies (8 papers) and Pulmonary Hypertension Research and Treatments (7 papers). David Tanous is often cited by papers focused on Congenital Heart Disease Studies (23 papers), Coronary Artery Anomalies (8 papers) and Pulmonary Hypertension Research and Treatments (7 papers). David Tanous collaborates with scholars based in Australia, Canada and New Zealand. David Tanous's co-authors include Lee Benson, Eric Horlick, David S. Celermajer, Samuel C. Siu, Roland Stocker, Candice K. Silversides, John D. Parker, Rachel M. Wald, Dan Jackson and Mathew Sermer and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

David Tanous

32 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Tanous Australia 13 432 389 352 274 98 36 775
Andreas Boening Germany 20 218 0.5× 586 1.5× 317 0.9× 464 1.7× 57 0.6× 66 1.0k
Shigeaki Ohtake Japan 16 171 0.4× 276 0.7× 225 0.6× 426 1.6× 68 0.7× 84 837
H.Storm Floten United States 15 206 0.5× 470 1.2× 204 0.6× 479 1.7× 149 1.5× 27 1.2k
Radhakrishnan Ravikumar India 13 269 0.6× 424 1.1× 320 0.9× 173 0.6× 53 0.5× 21 907
Alberto Froio Italy 9 232 0.5× 273 0.7× 401 1.1× 80 0.3× 213 2.2× 25 683
Benedetta De Chiara Italy 14 176 0.4× 494 1.3× 101 0.3× 118 0.4× 72 0.7× 51 726
Andrea Willfort‐Ehringer Austria 15 130 0.3× 232 0.6× 415 1.2× 309 1.1× 63 0.6× 34 670
Yasufumi Kijima Japan 17 260 0.6× 451 1.2× 322 0.9× 140 0.5× 22 0.2× 55 722
Hülya Çiçekçioğlu Türkiye 11 95 0.2× 226 0.6× 97 0.3× 167 0.6× 49 0.5× 36 558
Giovanni Sorropago Italy 16 345 0.8× 629 1.6× 443 1.3× 416 1.5× 35 0.4× 34 1.1k

Countries citing papers authored by David Tanous

Since Specialization
Citations

This map shows the geographic impact of David Tanous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tanous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tanous more than expected).

Fields of papers citing papers by David Tanous

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tanous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tanous. The network helps show where David Tanous may publish in the future.

Co-authorship network of co-authors of David Tanous

This figure shows the co-authorship network connecting the top 25 collaborators of David Tanous. A scholar is included among the top collaborators of David Tanous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Tanous. David Tanous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanous, David, et al.. (2025). Takotsubo cardiomyopathy following ergometrine administration during caesarean section. BMJ Case Reports. 18(12). e268219–e268219.
2.
Baker, David W., Melissa Lee, Julian Ayer, et al.. (2024). Transcatheter occlusion of venovenous collaterals in the total cavopulmonary Fontan circulation. Cardiology in the Young. 34(10). 2201–2206.
3.
Zannino, Diana, Thomas L. Gentles, Julian Ayer, et al.. (2023). Ventricular Arrhythmia in the Fontan Circulation: Prevalence, Risk Factors and Clinical Implications. Congenital Heart Disease. 18(5). 507–523. 1 indexed citations
4.
Collins, Nicholas, et al.. (2022). Platypnea‐Orthodeoxia Syndrome in the Setting of Patent Foramen Ovale Without Pulmonary Hypertension or Major Lung Disease. Journal of the American Heart Association. 11(15). e024609–e024609. 8 indexed citations
5.
Tanous, David, et al.. (2022). A case series describing the multidisciplinary management of pulmonary arterial hypertension in pregnancy: Time for optimism. Australian and New Zealand Journal of Obstetrics and Gynaecology. 63(1). 66–73. 2 indexed citations
6.
Tanous, David, Clare O’Donnell, D. Walters, et al.. (2022). Ten Years of Percutaneous Pulmonary Valve Implantation in Australia and New Zealand. Heart Lung and Circulation. 31(12). 1649–1657.
7.
Campbell, Timothy, et al.. (2019). Left Ventricular Outflow Tract Ventricular Tachycardia Late Post-Arterial Switch for D-Transposition of the Great Arteries. JACC. Clinical electrophysiology. 5(9). 1096–1097. 2 indexed citations
8.
Gentles, Thomas L., Geoff Strange, David Tanous, et al.. (2018). Adult Congenital Heart Disease in Australia and New Zealand: A Call for Optimal Care. Heart Lung and Circulation. 28(4). 521–529. 8 indexed citations
9.
Ganigara, Madhusudan, David Tanous, David S. Celermajer, & Rajesh Puranik. (2014). The role of cardiac MRI in the diagnosis and management of sinus venosus atrial septal defect. Annals of Pediatric Cardiology. 7(2). 160–160. 6 indexed citations
10.
O’Meagher, S., Madhusudan Ganigara, David Tanous, David S. Celermajer, & Rajesh Puranik. (2014). Progress of right ventricular dilatation in adults with repaired tetralogy of Fallot and free pulmonary regurgitation. PubMed. 3. 28–31. 2 indexed citations
11.
O’Meagher, S., Phillip A. Muñoz, Vivek Muthurangu, et al.. (2014). Mechanisms of maintained exercise capacity in adults with repaired tetralogy of Fallot. International Journal of Cardiology. 177(1). 178–181. 17 indexed citations
12.
O’Meagher, S., Madhusudan Ganigara, Phillip A. Muñoz, et al.. (2013). Right Ventricular Outflow Tract Enlargement Prior to Pulmonary Valve Replacement is Associated with Poorer Structural and Functional Outcomes, in Adults with Repaired Tetralogy of Fallot. Heart Lung and Circulation. 23(5). 482–488. 9 indexed citations
13.
Stoodley, Paul, David Tanous, David Richards, et al.. (2012). Trastuzumab‐Induced Cardiotoxicity: The Role of Two‐Dimensional Myocardial Strain Imaging in Diagnosis and Management. Echocardiography. 29(6). E137–40. 9 indexed citations
14.
Tanous, David, Samuel C. Siu, Jennifer Mason, et al.. (2010). B-Type Natriuretic Peptide in Pregnant Women With Heart Disease. Journal of the American College of Cardiology. 56(15). 1247–1253. 127 indexed citations
15.
Dos, Laura, David Tanous, Ignacio Ferreira‐González, et al.. (2009). Pulmonary valve replacement in repaired tetralogy of Fallot: Determinants of early postoperative adverse outcomes. Journal of Thoracic and Cardiovascular Surgery. 138(3). 553–559. 37 indexed citations
16.
Schwerzmann, Markus, Olga Hajnalka Bálint, David Tanous, et al.. (2008). Exercise capacity and biventricular function in adult patients with repaired tetralogy of Fallot. American Heart Journal. 156(1). 100–105. 27 indexed citations
17.
Tanous, David, Neil J. Hime, & Roland Stocker. (2008). Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds. Redox Report. 13(2). 48–59. 20 indexed citations
18.
Wu, Ben J., Krishna Kathir, Paul K. Witting, et al.. (2006). Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. The Journal of Experimental Medicine. 203(4). 1117–1127. 125 indexed citations
19.
Tanous, David, Jan Hinrich Bräsen, Katherine Choy, et al.. (2006). Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis. 189(2). 342–349. 31 indexed citations
20.
Geary, Grayson G., David Tanous, & David L. Ross. (2003). Incidence of renal artery stenosis in 2,111 patients undergoing coronary angiography: A model of predictive risk of renal artery stenosis. Journal of the American College of Cardiology. 41(6). 7–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Boening Breakdown of academic impact, for papers by Shigeaki Ohtake Breakdown of academic impact, for papers by H.Storm Floten Breakdown of academic impact, for papers by Radhakrishnan Ravikumar Breakdown of academic impact, for papers by Alberto Froio Breakdown of academic impact, for papers by Benedetta De Chiara Breakdown of academic impact, for papers by Andrea Willfort‐Ehringer Breakdown of academic impact, for papers by Yasufumi Kijima Breakdown of academic impact, for papers by Hülya Çiçekçioğlu Breakdown of academic impact, for papers by Giovanni Sorropago
Rankless by CCL
2026